Suppr超能文献

华法林治疗开始时蛋白C和S以及凝血因子II、VII、IX和X的下降。

Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy.

作者信息

Weiss P, Soff G A, Halkin H, Seligsohn U

出版信息

Thromb Res. 1987 Mar 15;45(6):783-90. doi: 10.1016/0049-3848(87)90088-0.

Abstract

Oral anticoagulants achieve an antithrombotic effect only several days after initiation of treatment. A rapid decline of the vitamin-K dependent natural anticoagulants (proteins C and S) during this period might result in a prothrombic phase. We addressed this question by measuring the rates of decline of these proteins, as well as the vitamin K dependent procoagulants, in two groups of patients: A "high dose group" (n = 7), who received a single 40 mg dose of warfarin, and a "low dose group" (n = 20), who received daily individually adjusted doses. In the high dose group an early and marked decline of factor VII:C and protein C antigen was observed, while levels of the other vitamin K dependent factors were still relatively high. In the low dose group, all these proteins declined more gradually. Mean +/- SD of protein C antigen level at 46 hr was 56 +/- 12% in the low dose group, and only 44 +/- 6% (p less than 0.05) in the high dose group. We conclude that during the initiation of warfarin therapy there is a transient prothrombotic phase, which is less marked in patients given daily adjusted doses.

摘要

口服抗凝剂在开始治疗几天后才会产生抗血栓作用。在此期间,维生素K依赖的天然抗凝剂(蛋白C和蛋白S)迅速下降可能会导致血栓形成前期。我们通过测量两组患者中这些蛋白以及维生素K依赖的促凝血剂的下降速率来解决这个问题:一组“高剂量组”(n = 7),接受单次40毫克剂量的华法林;另一组“低剂量组”(n = 20),接受每日个体化调整剂量。在高剂量组中,观察到因子VII:C和蛋白C抗原早期显著下降,而其他维生素K依赖因子的水平仍相对较高。在低剂量组中,所有这些蛋白下降更为缓慢。低剂量组在46小时时蛋白C抗原水平的平均值±标准差为56±12%,而高剂量组仅为44±6%(p<0.05)。我们得出结论,在华法林治疗开始期间存在一个短暂的血栓形成前期,在接受每日调整剂量的患者中这种情况不太明显。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验